Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders
Review
[키워드] acute respiratory syndrome
anti-TNF therapies
Autoimmune
autoinflammatory disease
caused
cohorts
coronavirus
coronavirus disease
COVID-19
COVID-19 incidence
CVD
Cytokine storm syndrome
develop
diabetes
disease
Diseases
disorder
disorders
displaying
Hospitalization
hypertension
immunosuppressive
Implications
incidence
increased risk
Infection
Inflammatory
Innate immunity
joint
Lung disease
Male sex
monotherapy
Older age
Other
outcome
pandemic
pathogenic mechanism
Patient
presence of comorbidity
psoriatic arthritis
question
raised
renal
rheumatoid arthritis
risk factor
SARS-CoV-2
SARS-COV-2 infection
severe COVID-19
severity
shown
specific patient group
Spondiloarthritis
Spread
susceptibility
Taking
therapy
virus
[DOI] 10.1186/s42358-021-00204-5 PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s42358-021-00204-5 PMC 바로가기 [Article Type] Review